TY - JOUR
T1 - Update on injection augmentation pharyngoplasty in the treatment of velopharyngeal insufficiency
AU - Kelly, Zachary
AU - Nassar, Michel
N1 - Publisher Copyright:
© 2023 Lippincott Williams and Wilkins. All rights reserved.
PY - 2023/8/1
Y1 - 2023/8/1
N2 - Purpose of reviewVelopharyngeal insufficiency (VPI) refers to a structural defect resulting in incomplete closure between the soft palate and posterior pharyngeal wall, leading to inadequate speech and deglutition. Traditional surgical options for VPI include sphincter pharyngoplasty, pharyngeal flaps and palatoplasty. Although these procedures have been successfully used over the past several decades, they are associated with complications such as pain, bleeding, infection and obstructive sleep apnoea. They also require postoperative admission. Injection augmentation pharyngoplasty (IAP) is increasingly being viewed as a viable, less invasive surgical option for patients with mild to moderate VPI.Recent findingsBoth autologous fat and alloplastic synthetics have been used as injectable materials, with low morbidity and good speech outcomes. However, given the overall lack of standardization across studies, no single material has shown clear superiority.SummaryIAP is a promising alternative to more invasive surgeries in the treatment of patients with mild to moderate VPI. The purpose of this review is to provide an overview of this approach, with an emphasis on its safety and efficacy.
AB - Purpose of reviewVelopharyngeal insufficiency (VPI) refers to a structural defect resulting in incomplete closure between the soft palate and posterior pharyngeal wall, leading to inadequate speech and deglutition. Traditional surgical options for VPI include sphincter pharyngoplasty, pharyngeal flaps and palatoplasty. Although these procedures have been successfully used over the past several decades, they are associated with complications such as pain, bleeding, infection and obstructive sleep apnoea. They also require postoperative admission. Injection augmentation pharyngoplasty (IAP) is increasingly being viewed as a viable, less invasive surgical option for patients with mild to moderate VPI.Recent findingsBoth autologous fat and alloplastic synthetics have been used as injectable materials, with low morbidity and good speech outcomes. However, given the overall lack of standardization across studies, no single material has shown clear superiority.SummaryIAP is a promising alternative to more invasive surgeries in the treatment of patients with mild to moderate VPI. The purpose of this review is to provide an overview of this approach, with an emphasis on its safety and efficacy.
KW - AlloDerm
KW - autologous fat
KW - calcium hydroxyapatite
KW - dextranomer/hyaluronicacid copolymer
KW - hypernasality
KW - injection augmentation pharyngoplasty
KW - speech
KW - velopharyngeal insufficiency
UR - http://www.scopus.com/inward/record.url?scp=85164236248&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85164236248&partnerID=8YFLogxK
U2 - 10.1097/MOO.0000000000000901
DO - 10.1097/MOO.0000000000000901
M3 - Review article
C2 - 37387675
AN - SCOPUS:85164236248
SN - 1068-9508
VL - 31
SP - 281
EP - 285
JO - Current Opinion in Otolaryngology and Head and Neck Surgery
JF - Current Opinion in Otolaryngology and Head and Neck Surgery
IS - 4
ER -